ZERO WORLD RESEARCHアミノ酸・有機酸の学術文献データベース

Effects of Caffeine Intake on Endurance Running Performance and Time to Exhaustion: A Systematic Review and Meta-Analysis.

カフェイン摂取が持久走パフォーマンスと疲労困憊までの時間に及ぼす影響:系統的レビューとメタ分析 (機械翻訳の邦題)

Nutrients2022Wang Z, Qiu B, Gao J, et al.
研究デザインメタ分析
対象ヒト

記録の確認項目

研究デザイン
メタ分析
対象
ヒト
出版年
2022
出典
doi.org
抄録の表示
表示あり
出版状態
有効な記録
状態確認日
2026/08/17
収集日
2026/08/03
鮮度
確認期限内
確認段階
自動処理
記録状態
公開

日本語要約(機械生成)

本研究は、カフェイン摂取が持久走パフォーマンスに及ぼす影響を検討した既存研究の系統的レビューとメタ分析である。4つのデータベースから2022年10月5日までに発表されたランダム化比較試験21件(参加者254名)を対象とした。カフェイン用量は3〜9 mg/kgで、プラセボと比較した。メタ分析の結果、疲労困憊までの時間はカフェイン摂取により有意に改善し(Hedges' g = 0.392、中程度の効果)、タイムトライアルの完走時間も有意に短縮された(g = -0.101、小程度の効果)。サブグループ分析では、レクリエーションランナーとトレーニング済みランナーの両方で疲労困憊までの時間の改善が認められた。研究全体の質は不明から低リスクと評価された。カフェインは持久走のパフォーマンス向上に有効である可能性が示唆されたが、女性や最適用量についてはさらなる証拠が必要である。

この要約は公開抄録のみを根拠にAIが機械的に生成したものです。正確な内容は原文を確認してください。

抄録

Caffeine (1,3,7-trimethylxanthine) is one of the most widely consumed performance-enhancing substances in sport due to its well-established ergogenic effects. The use of caffeine is more common in aerobic-based sports due to the ample evidence endorsing the benefits of caffeine supplementation on endurance exercise. However, most of this evidence was established with cycling trials in the laboratory, while the effects of the acute intake of caffeine on endurance running performance have not been properly reviewed and meta-analyzed. The purpose of this study was to perform a systematic review and meta-analysis of the existing literature on the effects of caffeine intake on endurance running performance. A systematic review of published studies was performed in four different scientific databases (Medline, Scopus, Web of Science, and SportDiscus) up until 5 October 2022 (with no year restriction applied to the search strategy). The selected studies were crossover experimental trials in which the ingestion of caffeine was compared to a placebo situation in a single- or double-blind randomized manner. The effect of caffeine on endurance running was measured by time to exhaustion or time trials. We assessed the methodological quality of each study using Cochrane’s risk-of-bias (RoB 2) tool. A subsequent meta-analysis was performed using the random effects model to calculate the standardized mean difference (SMD) estimated by Hedges’ g and 95% confidence intervals (CI). Results: A total of 21 randomized controlled trials were included in the analysis, with caffeine doses ranging between 3 and 9 mg/kg. A total of 21 studies were included in the systematic review, with a total sample of 254 participants (220 men, 19 women and 15 participants with no information about gender; 167 were categorized as recreational and 87 were categorized as trained runners.). The overall methodological quality of studies was rated as unclear-to-low risk of bias. The meta-analysis revealed that the time to exhaustion in running tests was improved with caffeine (g = 0.392; 95% CI = 0.214 to 0.571; p < 0.001, magnitude = medium). Subgroup analysis revealed that caffeine was ergogenic for time to exhaustion trials in both recreational runners (g = 0.469; 95% CI = 0.185 to 0.754; p = 0.001, magnitude = medium) and trained runners (g = 0.344; 95% CI = 0.122 to 0.566; p = 0.002, magnitude = medium). The meta-analysis also showed that the time to complete endurance running time trials was reduced with caffeine in comparison to placebo (g = −0.101; 95% CI = −0.190 to −0.012, p = 0.026, magnitude = small). In summary, caffeine intake showed a meaningful ergogenic effect in increasing the time to exhaustion in running trials and improving performance in running time trials. Hence, caffeine may have utility as an ergogenic aid for endurance running events. More evidence is needed to establish the ergogenic effect of caffeine on endurance running in women or the best dose to maximize the ergogenic benefits of caffeine supplementation.

MeSH

Athletic PerformanceBicyclingCaffeineFemaleHumansMalePerformance-Enhancing SubstancesPhysical EnduranceRandomized Controlled Trials as TopicRunning

DOI 10.3390/nu15010148

PMID 36615805

原文・出典を見る →